id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-N-0493-0007,FDA,FDA-2010-N-0493,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approval; Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded",Notice,Notice of Approval,2014-10-08T04:00:00Z,2014,10,2014-10-08T04:00:00Z,,2017-01-26T17:37:58Z,2014-23956,0,0,09000064818b1c32
FDA-2010-N-0493-0006,FDA,FDA-2010-N-0493,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Additional Criteria
and Procedures for Classifying Overthe- Counter Drugs as Generally
Recognized as Safe and Effective and Not Misbranded",Notice,30 Day Proposed Information Collection,2014-06-25T04:00:00Z,2014,6,2014-06-25T04:00:00Z,2014-07-26T03:59:59Z,2017-01-26T17:37:08Z,2014-14767,0,0,090000648176560d
FDA-2010-N-0493-0005,FDA,FDA-2010-N-0493,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Additional Criteria and Procedures for Classifying Overthe-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded",Notice,60 Day Proposed Information Collection,2014-03-24T04:00:00Z,2014,3,2014-03-24T04:00:00Z,2014-05-24T03:59:59Z,2017-01-26T17:35:20Z,2014-06365,0,0,090000648167969c